Let the SPIN Begin
PHOTO: Maram_Manie
See also: http://www.scribd.com/doc/31647477/Andrew-Goldsworthy-Witness-Statement-April-2010
Replace these every slider sentences with your featured post descriptions.Go to Blogger edit html and find these sentences.Now replace these with your own descriptions.This theme is Bloggerized by Lasantha - Premiumbloggertemplates.com.
Replace these every slider sentences with your featured post descriptions.Go to Blogger edit html and find these sentences.Now replace these with your own descriptions.This theme is Bloggerized by Lasantha - Premiumbloggertemplates.com.
Replace these every slider sentences with your featured post descriptions.Go to Blogger edit html and find these sentences.Now replace these with your own descriptions.This theme is Bloggerized by Lasantha - Premiumbloggertemplates.com.
The take-home storyDr. Goldsworthy was a Lecturer in Biology (retired), Imperial College London, Copyrighted © 2010
To sum up, it is perfectly possible that unmodulated microwaves could mitigate the effects of Alzheimer’s disease, but modulated microwaves are likely to do more harm than good. So now may not be the time to buy granny a mobile phone, but we should nevertheless look more carefully at the effects of unmodulated radiation. It may really help, but we still need to proceed with great caution.
Avastin approved for brain cancer therapy
WASHINGTON, May 11 (UPI) -- The U.S. Food and Drug Administration has approved Avastin (bevacizumab) to treat patients with glioblastoma multiforme -- a form of brain cancer.
"GBM is a rapidly progressing cancer that invades brain tissue and can impact physical activities and mental abilities," the FDA said. "It affects about 6,700 persons in the United States every year."
Following initial treatment with surgery, radiation, and/or chemotherapy, the cancer nearly always returns, the agency said.
"This type of cancer is very resistant to therapy and thus challenging to treat," said Dr. Richard Pazdur, director of the FDA's Office of Oncology Drug Products. "Avastin provides a therapy for patients with progressive GBM who have not responded to other medications."
The FDA first approved Avastin in 2004 to treat metastatic cancer of the colon or rectum and it since has been approved for treatment of non-squamous, non-small cell lung cancer and metastatic breast cancer.
Avastin is manufactured by Genentech Inc. (NYSE:DNA) of San Francisco.